Cochlear Limited (ASX:COH)
149.99
-3.88 (-2.52%)
Nov 20, 2026, 4:10 PM AEDT
Cochlear Market Cap
Cochlear has a market cap or net worth of 9.81 billion as of November 20, 2026. It is the 2,798th most valuable company in the world and the 49th biggest in Australia. Its market cap has decreased by 44.41% in one year.
Market Cap
9.81B
Enterprise Value
9.83B
Revenue
2.35B
Global Rank
Country Rank
#49 Australia
PE Ratio
66.72
ChartMarket Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 9.81B, an increase of 22,103.17%. That is a compound annual growth rate of 19.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 9.81B | -42.46% |
| Dec 31, 2025 | 17.05B | -10.12% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyNovo | 601.03M |
| Imricor Medical Systems | 521.85M |
| Aroa Biosurgery | 170.36M |
| EBR Systems | 139.51M |
| EMVision Medical Devices | 138.97M |
| Lumos Diagnostics Holdings | 73.85M |
| SomnoMed | 65.93M |
| Cyclopharm | 59.72M |